Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease.

Friedman, S; Marion, J F; Scherl, E; Rubin, P H; Present, D H

Friedman, S; Marion, J F; Scherl, E; Rubin, P H; Present, D H.

Affiliation

Friedman S; Division of Gastroenterology, Mount Sinai Medical Center, New York, New York, USA. sfriedman1@partners.org

Inflamm Bowel Dis ; 7(1): 1-7, 2001 Feb.

Article in En | MEDLINE | ID: mdl-11233655

Subject(s)

Cyclosporine/pharmacology; Immunosuppressive Agents/pharmacology; Inflammatory Bowel Diseases/complications; Pyoderma Gangrenosum/drug therapy; Adrenal Cortex Hormones/pharmacology; Adult; Aged; Cyclosporine/administration & dosage; Drug Resistance; Female; Humans; Immunosuppressive Agents/administration & dosage; Infusions, Intravenous; Male; Mercaptopurine/administration & dosage; Middle Aged; Pyoderma Gangrenosum/pathology; Retrospective Studies; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Cyclosporine / Pyoderma Gangrenosum / Immunosuppressive Agents Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2001 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links